The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype
Abstract
We investigated in vitro the properties of selected populations of cancer stem‐like cells defined as tumorospheres that were obtained from human glioblastoma. We also assessed their potential and capability of differentiating into mature cells of the central nervous system. In vivo, their tumorigenicity was confirmed after transplantation into the brain of non‐obese diabetic/severe combined immunodeficient (NOD‐SCID) mice. The angiogenic potential of tumorospheres and glioblastoma‐derived cells grown as adherent cells was revealed by evaluating the release of angiogenic factors such as vascular endothelial growth factor and CXCL12 by ELISA, as well as by rat aortic ring assay. The proliferative response of tumorospheres in the presence of CXCL12 was observed for the first time. Multidrug resistance‐associated proteins 1 and 3 as well as other molecules conferring multidrug resistance were higher when compared with primary adherent cells derived from the same tumor. Finally, we obtained cells from the tumor developing after grafting that clearly expressed the putative neural stem cell marker CD133 as shown by FACS analysis and also nestin and CXCR4. The cells' positivity for glial fibrillary acidic protein was very low. Moreover these cells preserved their angiogenic potential. We conclude that human glioblastoma could contain tumor cell subsets with angiogenic and chemoresistance properties and that this chemoresistance potential is highly preserved by immature cells whereas the angiogenic potential is, to a higher extent, a property of mature cells. A better understanding of the features of these cell subsets may favor the development of more specifically targeted therapies. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,817
Imitola, J., Raddassi, K., Park, K. I., Mueller, F.-J., Nieto, M., Teng, Y. D., Frenkel, D., Li, J., Sidman, R. L., Walsh, C. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408258102 · Cited by 1,057
Möhle, R., Bautz, F., Rafii, S., Moore, M. A. S., Brugger, W., & Kanz, L. (1998) · Blood · doi:10.1182/blood.v91.12.4523 · Cited by 648
Chemotherapy resistance of glioblastoma stem cells
Eramo, A., Ricci-Vitiani, L., Zeuner, A., Pallini, R., Lotti, F., Sette, G., Pilozzi, E., Larocca, L. M., Peschle, C., & De Maria, R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401872 · Cited by 623
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
Nicosia, R. F., & Ottinetti, A. (1990) · PubMed · Cited by 597
Cancer stem cells in nervous system tumors
Singh, S. K., Clarke, I. D., Hide, T., & Dirks, P. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207946 · Cited by 569
Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
Bellail, A. C., Hunter, S. B., Brat, D. J., Tan, C., & Van Meir, E. G. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.013 · Cited by 526
Felding-Habermann, B., & Cheresh, D. A. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90036-p · Cited by 413
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
Chang, S. M. (2005) · JAMA · doi:10.1001/jama.293.5.557 · Cited by 362
Angiogenesis in Gliomas: Biology and Molecular Pathophysiology
Fischer, I., Gagner, J., Law, M., Newcomb, E. W., & Zagzag, D. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00115.x · Cited by 350
Nicosia, R. F., Nicosia, S. V., & Smith, M. (1994) · PubMed · Cited by 293
Xu, L., Fukumura, D., & Jain, R. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108347200 · Cited by 281
Neurosphere and neurosphere-forming cells: morphological and ultrastructural characterization
Bez, A., Corsini, E., Curti, D., Biggiogera, M., Colombo, A., Nicosia, R. F., Pagano, S. F., & Parati, E. A. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.061 · Cited by 265
Self-citationCXCR4 expression mediates glioma cell invasiveness
Ehtesham, M., Winston, J. A., Kabos, P., & Thompson, R. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209302 · Cited by 198
Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma
Calatozzolo, C., Gelati, M., Ciusani, E., Sciacca, F. L., Pollo, B., Cajola, L., Marras, C., Silvani, A., Vitellaro-Zuccarello, L., Croci, D., et al. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-6152-7 · Cited by 196
Self-citationDeterminants of Passive Drug Entry into the Central Nervous System
Habgood, M. D., Begley, D. J., & Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007001923498 · Cited by 131
Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma.
Tunici, P., Bissola, L., Lualdi, E., Pollo, B., Cajola, L., Broggi, G., Sozzi, G., & Finocchiaro, G. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-25 · Cited by 83
Salmaggi, A., Gelati, M., Pollo, B., Frigerio, S., Eoli, M., Silvani, A., Broggi, G., Ciusani, E., Croci, D., Boiardi, A., et al. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000024241.05346.24 · Cited by 79
Self-citationECM-mediated glioma cell invasion
Goldbrunner, R., Bernstein, J. J., & Tonn, J. (1998) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19981101)43:3<250::aid-jemt7>3.0.co;2-c · Cited by 72
Drug Resistance-associated Factors in Primary and Secondary Glioblastomas and their Precursor Tumors
Tews, D. S., Nissen, A. J., Külgen, C., & Gaumann, A. K. A. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006491405010 · Cited by 65
Expression of PECAM-1/CD31 Isoforms in Human Brain Gliomas
Aroca, F., Renaud, W., Bartoli, C., Bouvier-Labit, C., & Figarella-Branger, D. F. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006233816724 · Cited by 41
Neuronal adhesion molecule telencephalin induces rapid cell spreading of microglia
Mizuno, T., Yoshihara, Y., Kagamiyama, H., Ohsawa, K., Imai, Y., Kohsaka, S., & Mori, K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01984-8 · Cited by 34
Human neural stem cells express extra-neural markers
Parati, E. A., Bez, A., Ponti, D., de Grazia, U., Corsini, E., Cova, L., Sala, S., Colombo, A., Alessandri, G., & Pagano, S. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03291-7 · Cited by 33
Self-citation(2003) · PubMed
Cited by
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Vik-Mo, E. O., Nyakas, M., Mikkelsen, B. V., Moe, M. C., Due-Tønnesen, P., Suso, E. M. I., Sæbøe-Larssen, S., Sandberg, C., Brinchmann, J. E., Helseth, E., et al. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1453-3 · Cited by 315
Hattermann, K., Held-Feindt, J., Lucius, R., Müerköster, S. S., Penfold, M. E. T., Schall, T. J., & Mentlein, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3642 · Cited by 295
Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
Beier, D., Röhrl, S., Pillai, D. R., Schwarz, S., Kunz-Schughart, L. A., Leukel, P., Proescholdt, M., Brawanski, A., Bogdahn, U., Trampe-Kieslich, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6878 · Cited by 294
Metadata
- Authors
- Salmaggi, A., Boiardi, A., Gelati, M., Russo, A., Calatozzolo, C., Ciusani, E., Sciacca, F. L., Ottolina, A., Parati, E. A., La Porta, C., Alessandri, G., Marras, C., Croci, D., & De Rossi, M.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2006-09-15
- Volume
- 54
- Issue
- 8
- Pages
- 850-860
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2063916050
- Cited by
- 254
- References
- 32
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.